Health Officials Express Concern Over Detection Of Super-Resistant Gonorrhea Case In U.K.

CBS News: “Huge concern” about spread of super-resistant gonorrhea
“Health officials in the U.K. say a man contracted a strain of gonorrhea that is resistant to multiple drugs used to treat the infection. The ‘super-resistant’ infection is the first case of its kind in the country, and raises concerns about the growing problem of bacteria that don’t respond to standard treatments…” (Welch, 3/29).

NPR: Gonorrhea Strain Thwarts 2 Main Drugs, Raising Concerns It’s Becoming Untreatable
“…It’s the first report of a gonorrhea case worldwide that is resistant to both ceftriaxone and azithromycin, the pair of drugs typically effective in treating the disease, according to Public Health England, a U.K. government agency. The strain showed high-level resistance to azithromycin and resistance to ceftriaxone…” (Kennedy, 3/29).

Washington Post: ‘Our greatest fear’: Highly drug-resistant gonorrhea confirmed by health officials
“… ‘This is the first time a case has displayed such high-level resistance to both of these drugs and to most other commonly used antibiotics,’ Gwenda Hughes, who leads the sexually transmitted infection section at Public Health England, said Wednesday in a statement…” (Bever, 3/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.